Clinical Convergence™: Patient and Provider Perspectives in NSCLC: Initial Visit
Hematology-Oncology
Curriculum:
Clinical ConvergenceSM: Patient and Provider Perspectives in NSCLC
Clinical ConvergenceSM: Patient and Provider Perspectives in NSCLC
Credits:
1.5 AMA PRA Category 1 Credit(s) ™
1.5 AMA PRA Category 1 Credit(s) ™
Launch Date:
March 31, 2016
March 31, 2016
Expiration Date:
The accreditation for this activity has expired.
The accreditation for this activity has expired.
Primary Audience:
Oncology physicians, nurse practitioners, and physician assistants
Relevant Terms:
Non-small cell lung cancer (NSCLC)
Jared Weiss, MD
Jared Weiss, MD
Assistant Professor of Medicine
University of North Carolina Lineberger Comprehensive Cancer Center
Chapel Hill, NC
Bio
Jared Weiss, MD, is an assistant professor of medicine at the University of North Carolina Lineberger Comprehensive Cancer Center in Chapel Hill, North Carolina. He completed his BS in neuroscience at Brown University in Providence, Rhode Island; his Doctor of Medicine at Yale University School of Medicine in New Haven, Connecticut; his residency in internal medicine at Beth Israel Deaconess Medical Center in Boston; and his fellowship at the Hospital of the University of Pennsylvania in Philadelphia.Dr. Weiss’s teaching within the university is integrated with his clinical practice and research efforts. He is an active clinical trialist; he is currently the lead principal investigator (PI) on seven investigator-initiated trials and site PI on numerous others. Previous research has resulted in dozens of papers and abstracts.
Dr. Weiss is active in the area of direct patient education. He has generated more than 50 videos and articles for the cancer information website CancerGrace.org and also serves on its board. Dr. Weiss is an active advocate for lung cancer patients and serves on the board of the Lung Cancer Initiative of North Carolina. He is also active in physician education, travelling nationally as a discussant at American Society of Clinical Oncology and American Thoracic Society as well as delivering numerous continuing medical education lectures.
Hossein Borghaei, DO
Hossein Borghaei, DO
Chief, Thoracic Medical Oncology
Associate Professor, Department of Medical Oncology
Fox Chase Cancer Center
Philadelphia, PA
Bio
Hossein Borghaei, DO, is an associate professor in the department of medical oncology at the Fox Chase Cancer Center in Philadelphia. He completed his BS in biology at St. Joseph’s University; his MS in microbiology and immunology at Temple University; his DO at Philadelphia College of Osteopathic Medicine; his residency at Graduate Hospital; and his fellowship at the Fox Chase Cancer Center, all in Philadelphia.Dr. Borghaei has been involved in a number of early and late stage clinical trials in immunotherapy of patients with lung cancer, and he is the author and/or a co-author of several papers and abstracts. In 2011, he received the Robert Krigel Memorial Award for Teaching Excellence from the Fox Chase Cancer Center. Dr. Borghaei serves on the Non-Small Cell Lung Cancer Committee for the National Comprehensive Cancer Network and on the Thoracic Oncology Core Committee for the Eastern Cooperative Oncology Group.
| 1. | Utilize a comprehensive understanding of histopathologic and molecular underpinnings of non-small cell lung cancer (NSCLC) and efficacy and safety data for agents used to treat NSCLC to select the most appropriate personalized therapies | 2. | Implement the most effective treatment strategies for patients with NSCLC using current evidence-based guidelines for sequencing, combination chemotherapy, and targeted therapy |
| 3. | Engage patients with NSCLC in their healthcare by implementing effective shared decision-making strategies |
| 1. | Utilize a comprehensive understanding of histopathologic and molecular underpinnings of non-small cell lung cancer (NSCLC) and efficacy and safety data for agents used to treat NSCLC to select the most appropriate personalized therapies |
| 2. | Implement the most effective treatment strategies for patients with NSCLC using current evidence-based guidelines for sequencing, combination chemotherapy, and targeted therapy |
| 3. | Engage patients with NSCLC in their healthcare by implementing effective shared decision-making strategies |
PHYSICIAN CONTINUING MEDICAL EDUCATION
Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Postgraduate Institute for Medicine and RMEI, LLC. The Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation
The Postgraduate Institute for Medicine designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
DISCLOSURE OF CONFLICTS OF INTEREST
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflicts of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high-quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.
The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Postgraduate Institute for Medicine and RMEI, LLC. The Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation
The Postgraduate Institute for Medicine designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
DISCLOSURE OF CONFLICTS OF INTEREST
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflicts of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high-quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.
The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
- Jared Weiss, MD, has affiliations with AstraZeneca, Biodesix, Clovis Oncology, EMD Serono, and OncoPlex (Consulting); and AstraZeneca, Celgene, Novartis, and Merck (Research).
- Hossein Borghaei, DO, has affiliations with Boehringer Ingelheim, Bristol-Myers Squibb, Celgene, Clovis, Genentech, Lily, and Pfizer (Advisory Board/Consulting); and Bristol-Myers Squibb and Celgene (Non-CME/CME Services).
RMEI, LLC
- Jacqui Brooks, MBBCh, MRCPsych, has no affiliations with commercial interests to disclose.
- Sherri Kramer, MD, has no affiliations with commercial interests to disclose.
- Amy Reeve has no affiliations with commercial interests relative to the content to disclose.
Postgraduate Institute for Medicine
The following PIM planners and managers, Judi Smelker-Mitchek, RN, BSN, Trace Hutchison, PharmD, Samantha Mattiucci, PharmD, CHCP, and Jan Schultz, MSN, RN, CHCP, hereby state that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.
DISCLAIMER
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients' conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.
DISCLOSURE OF UNLABELED USE
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Estimated time to complete: 1.5 hours
Medium: Internet
Medium: Internet
FEE INFORMATION
There is no fee for this educational activity.
COMMERCIAL SUPPORT
This activity is supported by independent educational grants from Genentech and Lilly.
HOW TO RECEIVE CREDIT
By reviewing the course content and successfully completing the post-test and evaluation, physicians, nurse practitioners, and physician assistants are entitled to receive up to 1.5 AMA PRA Category 1 Credit(s)™. A statement of credit will be available to print from your user history page. Users must:
- Read the learning objectives and faculty disclosures.
- Participate in the activity.
- Complete the activity evaluation.
Physicians, nurse practitioners, and physician assistants who successfully complete the post-test and evaluation will receive CME credit. You must score 75% or higher on the post-test to receive credit for this activity. All other participants who successfully complete the post-test and evaluation will receive a certificate of participation.
COURSE VIEWING REQUIREMENTS
| Supported Browsers: Internet Explorer 9.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 Google Chrome 28.0+ for Windows, Mac OS, or Linux Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux Safari 6.0+ for Mac OSX 10.7 and above | Supported Phones & Tablets: Android 4.0.3 and above iPhone/iPad with iOS 6.1 or above |
© 2007-2024 HealthCourse, Inc. All rights reserved.
